Cagrilintide (5mg/10mg)
Long-Acting Amylin Analog — Companion to Semaglutide
Order Cagrilintide (5mg/10mg) online for laboratory research with US shipping options at checkout. Compare the listed vial options and current price, then add your selection to cart and continue to checkout. Review available COA records for the exact product, strength and lot. Research Use Only; not for human or veterinary use.
Browse GLP-1 & Metabolic listings
Cagrilintide is listed for glp-1 & metabolic laboratory research. Catalog vial contents are 5mg / 10mg; select the required strength before ordering. This material is supplied for Research Use Only, not as a medicine or a product for human or veterinary use.
Buy Cagrilintide online with US shipping
Paid, in-stock orders placed before 1:00 PM Central Time on business days are scheduled to ship the same day.
Standard domestic delivery generally takes 2–5 business days after dispatch, not after placing the order.
Enter your full shipping address at checkout to confirm available shipping methods and cost. Delivery varies by ZIP code and carrier; weekends, holidays and carrier delays can affect arrival. These are online shipping destinations, not local stores or pickup locations.
Cagrilintide shipping to New York, NY
Ordering for a research address in New York? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.
Cagrilintide shipping to Los Angeles, CA
Ordering for a research address in Los Angeles? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.
Cagrilintide shipping to Chicago, IL
Ordering for a research address in Chicago? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.
Cagrilintide shipping to Houston, TX
Ordering for a research address in Houston? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.
Cagrilintide shipping to Phoenix, AZ
Ordering for a research address in Phoenix? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.
Cagrilintide shipping to Miami, FL
Ordering for a research address in Miami? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.
Cagrilintide shipping to Atlanta, GA
Ordering for a research address in Atlanta? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.
Cagrilintide shipping to Seattle, WA
Ordering for a research address in Seattle? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.
Research Applications & Benefits
- Long-acting amylin receptor agonism
- Synergistic with GLP-1 agonists
- Targets satiety via separate pathway
- Once-weekly dosing
What is Cagrilintide?
Cagrilintide is an amylin analogue studied separately and alongside GLP-1 compounds. Amylin-associated signaling differs from the incretin receptor pathways of semaglutide.
Listed vial contents: 5mg / 10mg. These are supplied quantities, not administration doses. Current pricing and availability are shown in the strength selector.
What mechanisms are being studied?
Research compares amylin-linked responses, clinical weight measurements and combination effects. Complementary receptor pathways alone do not establish synergy or improved tolerability.
What are the research questions?
- Amylin versus GLP-1 pathways
- Combination versus component comparisons
- Clinical estimands and adverse-event interpretation
What does the published work describe?
The randomized REDEFINE 1 trial compared coadministered cagrilintide and semaglutide with component comparators and placebo over 68 weeks. Combination results must not be attributed to cagrilintide alone, and percentages must retain the same population and analysis method.
Experimental models in the cited papers
- Randomized phase 3a human combination and component-comparator trial
What could future research explore?
Matched experiments can separate the constituent responses from the combination. A clinical coadministration study does not establish the composition or stability of a premixed catalog blend.
These are research directions, not established applications of the product sold here.
What are the limits of this evidence?
The trial does not verify this vial. Combination outcomes and tolerability cannot be reassigned to single-agent inventory.
Study references
How should I check lot documentation?
Match the product, strength and lot to an original analysis document. Literature describes experimental findings; it does not verify the contents of this inventory. A report is evidence only for the product, strength and lot it names.
How is Cagrilintide handled in the lab?
For Cagrilintide, record the product code CAGRI-5, selected strength and lot before opening. Follow the material-specific safety data sheet and laboratory SOP, with appropriate gloves, eye protection and containment. For a documented dry preparation, let the sealed vial equilibrate before opening to reduce condensation; minimize time open and use clean, compatible vessels.
Choose a solvent for Cagrilintide from the documented sequence or chemical identity, salt form and assay requirements. Test a small portion first and record pH, solvent composition and clarity. Do not assume one diluent works for every research material; include a solvent-only control and establish compatibility before using the stock in an assay. For a documented lipid-modified construct, evaluate aggregation and adsorption as well as apparent solubility; check compatibility again after dilution into the final assay buffer.
For Cagrilintide, calculate mass concentration as measured material mass divided by final solution volume. Calculate molarity only with a documented molecular weight for the supplied chemical form; the catalog lists 3789.43 g/mol as a reference, not lot confirmation. Where available, use matched-lot net content rather than treating chromatographic purity as a mass correction. Record both stock concentration and subsequent dilution factors.
Use the documented storage conditions for the supplied Cagrilintide form and lot. For a documented lyophilized preparation, keep the vial sealed and protected from moisture; for solutions, validate temperature, light exposure and holding time in the assay. Use compatible single-use aliquots when appropriate to reduce repeated freeze-thaw. No universal temperature or 28-day solution shelf life is established by the catalog name.
A Cagrilintide laboratory protocol should record identity, product code CAGRI-5, strength, lot, applicable analysis results, solvent and pH, stock concentration, dilution sequence, vessel type, storage history and assay endpoints. Include vehicle and reference controls, independent replicates and predefined acceptance criteria. Separate handling validation from biological interpretation; these notes do not provide administration or dosing instructions.
Research Use Only. Not for human consumption, therapeutic, veterinary or any in-vivo use.
Product Specifications
- Compound
- Cagrilintide
- CAS Number
- 1415456-99-3
- Molecular Weight
- 3789.43 g/mol
- HPLC Purity Specification
- ≥98%
- Category
- GLP-1 & Metabolic
- Starting Price
- $99.00 USD
- Country of Origin
- United States
- Shipping
- Cold-chain insulated packaging, fast domestic delivery
- Payment
- Card, ACH, and cryptocurrency (10% discount)
Quality & Verification
Cagrilintide has a catalog purity specification of ≥98%; this is not a measured result for every vial. Match the product, exact strength, batch and lot to its analysis record and read only the reported fields. HPLC peak-area purity, measured content and endotoxin are separate measurements. A blank field means no result is reported, not zero or passed. A purity percentage alone does not establish identity, sterility or suitability for human use.
Frequently Asked Questions
What is Cagrilintide?
Cagrilintide is listed for glp-1 & metabolic laboratory research. Catalog vial contents are 5mg / 10mg; select the required strength before ordering. This material is supplied for Research Use Only, not as a medicine or a product for human or veterinary use.
What strengths of Cagrilintide are available?
The catalog lists 5mg / 10mg. These labels describe vial contents, not administration doses. Select the required strength for current pricing and availability; match analysis records to that exact strength and lot.
How should I interpret Cagrilintide purity results?
Cagrilintide has a catalog purity specification of ≥98%; this is not a measured result for every vial. Match the product, exact strength, batch and lot to its analysis record and read only the reported fields. HPLC peak-area purity, measured content and endotoxin are separate measurements. A blank field means no result is reported, not zero or passed. A purity percentage alone does not establish identity, sterility or suitability for human use.
How should Cagrilintide be handled in the laboratory?
For Cagrilintide, record the product code CAGRI-5, selected strength and lot before opening. Follow the material-specific safety data sheet and laboratory SOP, with appropriate gloves, eye protection and containment. For a documented dry preparation, let the sealed vial equilibrate before opening to reduce condensation; minimize time open and use clean, compatible vessels.
How do I choose a laboratory solvent for Cagrilintide?
Choose a solvent for Cagrilintide from the documented sequence or chemical identity, salt form and assay requirements. Test a small portion first and record pH, solvent composition and clarity. Do not assume one diluent works for every research material; include a solvent-only control and establish compatibility before using the stock in an assay. For a documented lipid-modified construct, evaluate aggregation and adsorption as well as apparent solubility; check compatibility again after dilution into the final assay buffer.
How do I calculate a Cagrilintide stock concentration?
For Cagrilintide, calculate mass concentration as measured material mass divided by final solution volume. Calculate molarity only with a documented molecular weight for the supplied chemical form; the catalog lists 3789.43 g/mol as a reference, not lot confirmation. Where available, use matched-lot net content rather than treating chromatographic purity as a mass correction. Record both stock concentration and subsequent dilution factors.
How should Cagrilintide be stored after preparation?
Use the documented storage conditions for the supplied Cagrilintide form and lot. For a documented lyophilized preparation, keep the vial sealed and protected from moisture; for solutions, validate temperature, light exposure and holding time in the assay. Use compatible single-use aliquots when appropriate to reduce repeated freeze-thaw. No universal temperature or 28-day solution shelf life is established by the catalog name.
What should a Cagrilintide lab protocol document?
A Cagrilintide laboratory protocol should record identity, product code CAGRI-5, strength, lot, applicable analysis results, solvent and pH, stock concentration, dilution sequence, vessel type, storage history and assay endpoints. Include vehicle and reference controls, independent replicates and predefined acceptance criteria. Separate handling validation from biological interpretation; these notes do not provide administration or dosing instructions.
Does Fmoc or Boc synthesis explain this Cagrilintide product?
Fmoc and Boc are peptide protecting-group strategies, not proof of how this Cagrilintide lot was made. For sequence-defined peptides, synthesis review can examine deletion products, incomplete deprotection and modifications using the method and matching analytical evidence. A single chromatographic peak does not by itself establish sequence.
Is Cagrilintide for human use?
No. Cagrilintide is strictly Research Use Only. It is not intended for human or veterinary use, diagnosis or treatment. Laboratory handling guidance is not an administration protocol.
Research Use Only. This product is intended for licensed laboratory research and is not for human or veterinary use.
